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Summary of: Maltais F, Bourbeau J, Shapiro S et al (2008) 
Effects of home-based pulmonary rehabilitation in patients 
with chronic obstructive pulmonary disease: a randomized 
trial. Ann Intern Med 149: 869–878. [Prepared by Mark 
Elkins, CAP Co-ordinator.]
Question: Is pulmonary rehabilitation with the exercise 
component performed at home as effective at reducing 
dyspnoea as outpatient pulmonary rehabilitation? Design: 
Randomised, controlled trial with concealed allocation. 
Setting: Ten centres in Canada. Participants: Adults with 
stable chronic obstructive pulmonary disease (COPD), aged 
at least 40 years, with an FEV1 less than 70% of the predicted 
value, an FEV1/FVC ratio of less than 0.70, and a Medical 
Research Council dyspnoea score of 2 or more. Previous 
pulmonary rehabilitation was an exclusion criterion. 
Randomisation of 252 participants allotted 126 to each 
group. Interventions: Both groups received the same eight 
educational lectures over 4 weeks as hospital outpatients. 
The outpatient group then commenced combined aerobic 
and strength training on an outpatient basis with supervision, 
attending three sessions per week for 8 weeks. Each session 
consisted of cycle ergometry for 30 minutes at 80% of peak 
work capacity and progressive resistance exercises for 30 
minutes. Supplemental oxygen was provided as appropriate. 
The other group trained at home, also for three sessions per 
week over the same 8 weeks. The first session was supervised, 
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followed by weekly phone contact. Cycle ergometers were 
loaned to participants for the aerobic training for the 8-week 
period. The target intensity was 60% of peak work capacity 
for 40 minutes per session. The resistance exercises and 
oxygen supplementation were the same as for the outpatient 
group. Thereafter, both groups were prescribed three home 
exercise sessions per week for another 9 months. Outcome 
measures: The primary outcome was the change in the 
dyspnoea domain of the Chronic Respiratory Questionnaire 
(CRQ) at 12 months. Secondary outcomes were other 
CRQ domains, the St George’s Respiratory Questionnaire 
(SGRQ), the 6-minute walk test, an endurance cycle test, 
and safety. Results: Follow-up was 92% at 3 months and 
86% at one year. The CRQ dyspnoea scores differed by 
0.05 (95%CI –0.21 to 0.29) at 3 months and by 0.16 (95% 
CI –0.08 to 0.40) at one year. This excluded the minimum 
clinically important difference of 0.5, confirming that the 
two rehabilitation strategies had very similar effects on 
dyspnoea. The home-based group showed significantly 
better improvement on the Symptoms domain of the SGRQ 
at 3 months, but this difference was no longer significant at 
one year. On the remaining secondary outcomes, the two 
rehabilitation strategies had similar effects. Conclusion: 
For adults with COPD, pulmonary rehabilitation with the 
exercise component performed at home can be as effective 
as outpatient pulmonary rehabilitation.
Commentary
Pulmonary rehabilitation (PR) is one of the few interventions 
that improves exercise capacity and health-related quality of 
life (HRQOL) in people with COPD. However, the lack of 
access to PR (approximately only 1–2%) limits the number 
of COPD patients that can benefit. Therefore, recent studies 
have focused on ways to improve access.
This large randomised, controlled, multi-centre study 
provides strong evidence that a home-based PR program 
is as effective as a hospital-based program in reducing 
dyspnoea and improving HRQOL, both immediately 
following completion of a 4-week education plus 8-week 
cycle and resistance training program and after a further 
9 months maintenance program where encouragement to 
continue to exercise was provided by telephone contact 
every 2 months.
Clinicians should note that the home PR was provided by 
placing a cycle ergometer in the home for 8 weeks. This 
may not be a feasible option in many settings. For safety, 
the cycle training intensity was reduced in the home-based 
program to 60% peak work, from 80% in the hospital-
based program. Previous studies in COPD cohorts with 
similar characteristics have shown that 60% of peak work 
capacity is effective in eliciting a training effect (Maltais et 
al 1996). Since no adverse events specifically related to the 
exercise training were evident, this intensity of training was 
considered safe for home-based training, even in those with 
co-morbid conditions, provided that patients were reviewed 
by a physician and successfully completed a maximum 
cycle exercise test prior to commencing training. Again, the 
feasibility of providing such tests may limit the applicability 
of this type of screening.
While improving HRQOL and dyspnoea, the chosen training 
mode (cycling) resulted in only a small, albeit significant, 
increase in functional exercise capacity as measured by six-
minute walk distance, which was well below the minimum 
clinically important difference. It will be important to 
determine whether other modes of home-based exercise 
training, eg walking, can achieve more meaningful 
improvements in such an important daily activity.
This study encourages clinicians to consider alternatives 
to hospital-based PR by adding to the growing body of 
literature that provides evidence that individually tailored, 
home-based PR programs are effective for people with 
COPD.
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